Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 11388527)

Published in Anesthesiology on May 01, 2001

Authors

G A Nuttall1, W C Oliver, P J Santrach, S Bryant, J A Dearani, H V Schaff, M H Ereth

Author Affiliations

1: Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota 55905, USA. nuttall.gregory@mayo.edu

Associated clinical trials:

PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding | NCT02557672

Articles citing this

Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth (2009) 1.24

Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy. Transfus Med Hemother (2012) 1.08

Point-of-care coagulation management in intensive care medicine. Crit Care (2013) 0.94

Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. Interact Cardiovasc Thorac Surg (2012) 0.91

Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery. J Anesth (2007) 0.89

Fibrinogen availability and coagulation function after hemorrhage and resuscitation in pigs. Mol Med (2011) 0.85

Association of the 98T ELAM-1 polymorphism with increased bleeding after cardiac surgery. J Cardiothorac Vasc Anesth (2010) 0.81

Perioperative point of care coagulation testing. Dtsch Arztebl Int (2012) 0.78

High mortality associated with intracardiac and intrapulmonary thromboses after cardiopulmonary bypass. J Anesth (2011) 0.77

Does point of care prothrombin time measurement reduce the transfusion of fresh frozen plasma in patients undergoing major surgery? The POC-OP randomized-controlled trial. Trials (2009) 0.77

Active Bleeding after Cardiac Surgery: A Prospective Observational Multicenter Study. PLoS One (2016) 0.75

Predictive value of rotational thromboelastometry during cardiopulmonary bypass for thrombocytopenia and hypofibrinogenemia after weaning of cardiopulmonary bypass. Korean J Anesthesiol (2015) 0.75

Point of care and factor concentrate-based coagulation algorithms. Transfus Med Hemother (2015) 0.75

The use of viscoelastic haemostatic assays in goal-directing treatment with allogeneic blood products - A systematic review and meta-analysis. Scand J Trauma Resusc Emerg Med (2017) 0.75

Coagulation Parameter Thresholds Associated with Non-Bleeding in the Eighth Hour of Adult Cardiac Surgical Post-Cardiotomy Extracorporeal Membrane Oxygenation. J Extra Corpor Technol (2016) 0.75

Articles by these authors

Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med (1997) 9.36

Coronary bypass surgery with internal-thoracic-artery grafts--effects on survival over a 15-year period. N Engl J Med (1996) 4.42

Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med (1996) 3.97

Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature (1994) 3.73

Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation (1999) 3.25

Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation (1995) 3.23

ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol (2001) 3.23

Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990). Mayo Clin Proc (1993) 3.14

Clinical and echocardiographic characteristics of significant pericardial effusions following cardiothoracic surgery and outcomes of echo-guided pericardiocentesis for management: Mayo Clinic experience, 1979-1998. Chest (1999) 2.92

Calcific constrictive pericarditis: is it still with us? Ann Intern Med (2000) 2.81

Surgical treatment of vascular rings: the Mayo Clinic experience. Mayo Clin Proc (1993) 2.63

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation (2001) 2.62

Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements. Nature (1994) 2.61

Comparison of LightCycler PCR, rapid antigen immunoassay, and culture for detection of group A streptococci from throat swabs. J Clin Microbiol (2003) 2.57

The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell (1991) 2.56

Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement? J Thorac Cardiovasc Surg (2005) 2.46

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia (2003) 2.28

Five- to fifteen-year follow-up after Fontan operation. Circulation (1992) 2.26

Early and late survival after surgical treatment of culture-positive active endocarditis. Mayo Clin Proc (1995) 2.17

Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction:result of aortic valve replacement in 52 patients. Circulation (2000) 2.14

Possible guidelines for autologous red blood cell donations before total hip arthroplasty based on the surgical blood order equation. Mayo Clin Proc (2000) 2.13

The significance of multiple, recurrent, and "complex" cardiac myxomas. J Thorac Cardiovasc Surg (1986) 2.12

Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol (1994) 2.08

Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation (1999) 2.06

Diagnostic role of Doppler echocardiography in constrictive pericarditis. J Am Coll Cardiol (1994) 2.05

Autologous platelet-rich plasma does not reduce transfusion of homologous blood products in patients undergoing repeat valvular surgery. Anesthesiology (1993) 2.04

Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol (1990) 2.01

Population genetics of modifiers of meiotic drive. I. The solution of a special case and some general implications. Theor Popul Biol (1973) 2.01

Detrimental haemodynamic effects of cyclizine in heart failure. Lancet (1988) 1.96

Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up. J Am Coll Cardiol (1991) 1.96

Cerebral blood flow during cardiac operations: comparison of Kety-Schmidt and xenon-133 clearance methods. Ann Thorac Surg (1995) 1.96

Primary cardiac angiosarcoma: a clinicopathologic study of six cases. J Thorac Cardiovasc Surg (1992) 1.91

Mitral valve operation in postinfarction rupture of a papillary muscle: immediate results and long-term follow-up of 22 patients. Mayo Clin Proc (1992) 1.90

Traumatic tricuspid valve insufficiency. Experience in thirteen patients. J Thorac Cardiovasc Surg (1994) 1.89

Coronary arteriography and coronary artery bypass surgery: morbidity and mortality in patients ages 65 years or older. A report from the Coronary Artery Surgery Study. Circulation (1983) 1.83

Single versus bilateral internal mammary artery grafts: 10-year outcome analysis. Ann Thorac Surg (1997) 1.82

A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med (1982) 1.82

Improved prognosis of thoracic aortic aneurysms: a population-based study. JAMA (1998) 1.81

Congestive heart failure after surgical correction of mitral regurgitation. A long-term study. Circulation (1995) 1.79

Natriuretic peptide system in human heart failure. Circulation (1993) 1.79

Cor triatriatum: diagnosis, operative approach, and late results. Mayo Clin Proc (1993) 1.77

Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry. Circulation (1992) 1.75

The Frank Stinchfield Award. Sudden death during primary hip arthroplasty. Clin Orthop Relat Res (1999) 1.74

Mechanism of activation of the vav protooncogene. Cell Growth Differ (1991) 1.71

Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth (1997) 1.70

A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation (1995) 1.70

A computer program to make linkage analysis with LIPED and LINKAGE easier to perform and less prone to input errors. Ann Hum Genet (1988) 1.70

Very long-term survival and durability of mitral valve repair for mitral valve prolapse. Circulation (2001) 1.66

Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg (1996) 1.65

Thirty-day mortality after elective total hip arthroplasty. J Bone Joint Surg Am (2001) 1.63

MMDB: an ASN.1 specification for macromolecular structure. Proc Int Conf Intell Syst Mol Biol (1995) 1.61

Outcome of valve repair and the Cox maze procedure for mitral regurgitation and associated atrial fibrillation. J Thorac Cardiovasc Surg (1999) 1.57

Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology (2000) 1.55

DR human leukocyte antigens and disease severity in chronic hepatitis C. J Hepatol (1996) 1.54

Long-term outcome of surgical repair of ruptured sinus of Valsalva aneurysm. Circulation (1994) 1.53

Cardiac transplantation for end-stage congenital heart defects: the Mayo Clinic experience. Mayo Cardiothoracic Transplant Team. Mayo Clin Proc (1998) 1.53

Late pulmonary valve replacement after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg (2001) 1.52

Operation for partial atrioventricular septal defect: a forty-year review. J Thorac Cardiovasc Surg (2000) 1.49

Genetic distinctions between types 1 and 2 autoimmune hepatitis. Am J Gastroenterol (1997) 1.49

Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study. Liver Transpl (2001) 1.48

Frequency of early occlusion and stenosis in a left internal mammary artery to left anterior descending artery bypass graft after surgery through a median sternotomy on conventional bypass: benchmark for minimally invasive direct coronary artery bypass. Circulation (1999) 1.47

The trkB tyrosine protein kinase is a receptor for neurotrophin-4. Neuron (1992) 1.47

Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine (Phila Pa 1976) (2000) 1.46

The relationship between cerebral blood flow and transcranial Doppler blood flow velocity during hypothermic cardiopulmonary bypass in adults. Anesth Analg (1996) 1.46

Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation (1994) 1.46

Safety and therapeutic effectiveness of reinfused shed blood after open heart surgery. Ann Thorac Surg (1994) 1.45

Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol (1983) 1.45

Ultrasonic aortic valve decalcification: serial Doppler echocardiographic follow-up. J Am Coll Cardiol (1990) 1.44

Nitric oxide inhibition attenuates systemic hypotension produced by protamine. J Thorac Cardiovasc Surg (1996) 1.44

Early and late results of pericardiectomy for constrictive pericarditis. J Thorac Cardiovasc Surg (1985) 1.43

Late results of valve replacement with the Björk-Shiley valve (1973 to 1982) J Thorac Cardiovasc Surg (1993) 1.43

Endothelium-dependent contraction and relaxation of the human and canine internal mammary artery: studies on bypass graft vasospasm. Surgery (1991) 1.43

Links from genome proteins to known 3-D structures. Genome Res (2000) 1.43

Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol (1998) 1.43

Use of coronary artery bypass surgical procedure and coronary angioplasty in treatment of coronary artery disease: changes during a 10-year period at Mayo Clinic Rochester. Mayo Clin Proc (1996) 1.42

Transmyocardial and percutaneous myocardial revascularization: current and future role in the treatment of coronary artery disease. Mayo Clin Proc (1999) 1.40

Perioperative ingestion of caffeine and postoperative headache. Mayo Clin Proc (1993) 1.40

Determination of normal versus abnormal activated partial thromboplastin time and prothrombin time after cardiopulmonary bypass. J Cardiothorac Vasc Anesth (1995) 1.40

Cox-Maze procedure for atrial fibrillation: Mayo Clinic experience. Semin Thorac Cardiovasc Surg (2000) 1.40

An in vitro study on the use of circumferential matrix bands in the placement of Class II amalgam restorations. Br Dent J (2008) 1.39

Impaired left ventricular function, one- or two-vessel coronary artery disease, and severe ischemia: outcome with medical therapy versus revascularization. Mayo Clin Proc (1994) 1.39

Percutaneous transluminal coronary angioplasty and the changing indications for coronary artery bypass grafting for single-vessel coronary artery disease. Mayo Clin Proc (1992) 1.38

Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older. A nonrandomized study from the Coronary Artery Surgery Study (CASS) registry. N Engl J Med (1985) 1.36

Low pressure giant pulmonary artery aneurysms in the adult: natural history and management strategies. Heart (2003) 1.35

Papillary muscle rupture complicating acute myocardial infarction: analysis of 17 patients. Am J Cardiol (1983) 1.35

Posterior pericardial ascending-to-descending aortic bypass: an alternative surgical approach for complex coarctation of the aorta. Circulation (2001) 1.34

The modified Fontan operation. An analysis of risk factors for early postoperative death or takedown in 702 consecutive patients from one institution. J Thorac Cardiovasc Surg (1995) 1.32

Exercise tolerance and cardiorespiratory response to exercise after the Fontan operation for tricuspid atresia or functional single ventricle. J Am Coll Cardiol (1986) 1.29

Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States. J Hepatol (1993) 1.29